Align Technology (ALGN) Research & Development (2009 - 2026)
Align Technology (ALGN) posted quarterly Research & Development of $98.7 million for Q1 2026, up 1.5% year-over-year from $97.2 million in Q1 2025, and up 18.81% quarter-over-quarter from $83.0 million in Q4 2025.
Align Technology (ALGN) Research & Development (2009 - 2026) Analysis & Trends
Align Technology (ALGN) has reported Research & Development for 18 consecutive years, with $98.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development rose 1.5% year-over-year to $98.7 million; the TTM figure through Mar 2026 stood at $371.4 million (changed 0.49% YoY), while the FY2025 annual figure was $369.9 million, up 1.57% from the prior year.
- Research & Development improved to $98.7 million in Q1 2026 per ALGN's latest filing, from $83.0 million in the prior quarter.
- Across five years, Research & Development topped out at $98.7 million in Q1 2026 and bottomed at $71.8 million in Q1 2022.
- Historically, Research & Development has averaged $87.3 million across 5 years, with a median of $88.5 million in 2023.
- Annual changes were most pronounced in 2022 — Research & Development soared 31.67% — and 2025, when it retreated 12.48%.
- Align Technology's Research & Development stood at $83.5 million in 2022, then decreased by 1.63% to $82.2 million in 2023, then advanced by 15.48% to $94.9 million in 2024, then fell by 12.48% to $83.0 million in 2025, then rose by 18.81% to $98.7 million in 2026.
- Business Quant data shows ALGN's Research & Development at $98.7 million in Q1 2026, $83.0 million in Q4 2025, and $93.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn | 102.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 102.03 Mn |
| Mar 31, 2026 | 98.66 Mn |
| Dec 31, 2025 | 83.04 Mn |
| Sep 30, 2025 | 93.28 Mn |
| Jun 30, 2025 | 96.40 Mn |
| Mar 31, 2025 | 97.20 Mn |
| Dec 31, 2024 | 94.88 Mn |
| Sep 30, 2024 | 85.27 Mn |
| Jun 30, 2024 | 92.19 Mn |
| Mar 31, 2024 | 91.86 Mn |
| Dec 31, 2023 | 82.16 Mn |
| Sep 30, 2023 | 88.74 Mn |
| Jun 30, 2023 | 88.49 Mn |
| Mar 31, 2023 | 87.45 Mn |
| Dec 31, 2022 | 83.52 Mn |
| Sep 30, 2022 | 76.97 Mn |
| Jun 30, 2022 | 72.97 Mn |
| Mar 31, 2022 | 71.81 Mn |
| Dec 31, 2021 | 72.48 Mn |
| Sep 30, 2021 | 65.59 Mn |